Publication Name	World Journal of Gastroenterology
Manuscript ID	85418
Country	Malaysia

Received	2023-04-26 15:26
Peer-Review Started	2023-04-26 15:28
To Make the First Decision
Return for Revision	2023-05-27 12:25
Revised	2023-06-11 04:51
Second Decision	2023-06-27 02:52
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-06-27 09:23
Articles in Press	2023-06-27 09:23
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-07-04 08:41
Publish the Manuscript Online	2023-07-13 08:46

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Serum resistin and the risk for hepatocellular carcinoma in diabetic patients
Manuscript Source	Invited Manuscript
All Author List	Mona Mohamed Ibrahim Abdalla
Funding Agency and Grant Number
Corresponding Author	Mona Mohamed Ibrahim Abdalla, MSc, PhD, Senior Lecturer, Department of Human Biology, School of Medicine, International Medical University, No. 126, Jln Jalil Perkasa 19, Bukit Jalil 57000, Kuala Lumpur, Malaysia. monamohamed@imu.edu.my
Key Words	Hepatocellular carcinoma; Resistin; Insulin resistance; Obesity; Diabetes; Liver cancer
Core Tip	Resistin, a hormone linked to the onset of insulin resistance and diabetes, could be involved in the development and advancement of hepatocellular carcinoma (HCC) in individuals with diabetes. Increased resistin levels have been observed in HCC patients and might be connected to a more severe disease stage and unfavourable prognosis. This review aims to assess the existing literature concerning the possible application of resistin as a biomarker for HCC development and monitoring while investigating the potential processes through which resistin influences HCC’s development and progression in diabetic patients. Gaining a better understanding of these processes may offer valuable insights for the prevention and therapy of this condition.
Publish Date	2023-07-13 08:46
Citation	Abdalla MMI. Serum resistin and the risk for hepatocellular carcinoma in diabetic patients. World J Gastroenterol 2023; 29(27): 4271-4288
URL	https://www.wjgnet.com/1007-9327/full/v29/i27/4271.htm
DOI	https://dx.doi.org/10.3748/wjg.v29.i27.4271

Full Article (PDF)	WJG-29-4271-with-cover.pdf
Full Article (Word)	WJG-29-4271.docx
Manuscript File	85418_Auto_Edited-JLW.docx
Answering Reviewers	85418-Answering reviewers.pdf
Audio Core Tip	85418-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	85418-Conflict-of-interest statement.pdf
Copyright License Agreement	85418-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	85418-Language certificate.pdf
Peer-review Report	85418-Peer-review(s).pdf
Scientific Misconduct Check	85418-Bing-Wang JJ-2.png
Scientific Editor Work List	85418-Scientific editor work list.pdf
CrossCheck Report	85418-CrossCheck report.pdf